AVXL Investors Have Opportunity to Join Anavex Life Sciences Corp. Fraud Investigation with the Schall Law Firm

Core Viewpoint - The Schall Law Firm is investigating Anavex Life Sciences Corp for potential violations of securities laws following a significant drop in share price after a negative trend vote on its Marketing Authorisation Application for blarcamesine [1] Group 1: Investigation Details - The investigation focuses on whether Anavex issued false or misleading statements or failed to disclose important information to investors [1] - Anavex announced on November 14, 2025, that it received a negative trend vote from the Committee for Medicinal Products for Human Use (CHMP) regarding its Marketing Authorisation Application for blarcamesine [1] Group 2: Market Reaction - Following the announcement of the negative trend vote, shares of Anavex fell by more than 35.9% on the same day [1]